Cite
Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose.
MLA
Ieiri, Ichiro, et al. “Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose.” Journal of Clinical Pharmacology, vol. 52, no. 7, July 2012, pp. 1078–89. EBSCOhost, https://doi.org/10.1177/0091270011408612.
APA
Ieiri, I., Doi, Y., Maeda, K., Sasaki, T., Kimura, M., Hirota, T., Chiyoda, T., Miyagawa, M., Irie, S., Iwasaki, K., & Sugiyama, Y. (2012). Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose. Journal of Clinical Pharmacology, 52(7), 1078–1089. https://doi.org/10.1177/0091270011408612
Chicago
Ieiri, Ichiro, Yohei Doi, Kazuya Maeda, Tomohiro Sasaki, Miyuki Kimura, Takeshi Hirota, Takeshi Chiyoda, et al. 2012. “Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose.” Journal of Clinical Pharmacology 52 (7): 1078–89. doi:10.1177/0091270011408612.